Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (118)	4/20/1998 12:14:00 AM
From: Steve Lokness	Respond to of 4974

Rick; Don't give up on all Yahoo post as the CPRO thread has some very intelligent conversations going about the merits of CPRO vrs VMRX/Baxter product. I would read post 133 going then to 144 and reading through to post 150. Also of interest might be 153,160,167 and post 171 is revealing. There are a few garbage post here and several later on but also many worth reading. How the heck did VMRX end up with over 55 million shares! Reminds me of CYTO. While the VMRX approach may work well in other business's I wonder how well it will work in the biotech arena? Just wondering out loud. Do you follow HYSQ at all? Steve